BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3884274)

  • 1. Antigen presenting cells and mechanisms of antigen presentation.
    Chesnut RW; Grey HM
    Crit Rev Immunol; 1985; 5(3):263-316. PubMed ID: 3884274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of antigen presentation by B cells to helper T cells].
    Zimecki M
    Postepy Hig Med Dosw; 1987; 41(4-5):349-83. PubMed ID: 2967469
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigen presentation at the inflammatory site.
    Geppert TD; Lipsky PE
    Crit Rev Immunol; 1989; 9(4):313-62. PubMed ID: 2679663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
    Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
    Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes.
    Brooks CF; Moore M
    Immunology; 1986 Jul; 58(3):343-50. PubMed ID: 3488259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
    González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
    Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
    Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
    Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
    Guéry JC; Adorini L
    J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in cellular antigen retention structures.
    Betancourt SV; Solvay MJ; Irani DN; Thomas DW; Nairn R
    J Immunol; 1987 Dec; 139(11):3725-9. PubMed ID: 3680948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigen processing and antigen presentation by accessory cells of the immune system].
    Langner J
    Allerg Immunol (Leipz); 1985; 31(3):131-56. PubMed ID: 2416210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by a subset of T8+ Ia+ cells to T4+ helper cells.
    Brines R; Lehner T
    Clin Exp Immunol; 1987 Feb; 67(2):398-405. PubMed ID: 2955972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.